Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Changes of Genes, Proteins, and Metabolites in Patients with Drug-resistant Epilepsy

NCT06665880 is registered in ClinicalTrials.gov with Xuanwu Hospital, Beijing as lead sponsor.

NCT NCT06665880
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06665880 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Changes of Genes, Proteins, and Metabolites in Patients with Drug-resistant Epilepsy
Lead sponsor
Xuanwu Hospital, Beijing
Phase
Observational
Overall status
Not yet recruiting
Start date
November 15, 2024
Completion date
December 31, 2026
Enrollment
16 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug resistant epilepsy, traumatic brain injury without open intracranial wound